Shacey Petrovic net worth and biography

Shacey Petrovic Biography and Net Worth

CEO of Insulet
Ms. Petrovic has served as our President and Chief Executive Officer since January 1, 2019 and has served on our Board of Directors since September 2018. She also serves on the Board of Directors of Exact Sciences Corporation. Prior to becoming Chief Executive Officer, she served as Insulet’s President and Chief Operating Officer from October 2016 to December 31, 2018. From February 2016 to October 2016, she served as our Executive Vice President and President, Diabetes Products, and from February 2015 to February 2016, she served as our Chief Commercial Officer. From 2013 to 2015, Ms. Petrovic served as President and Chief Executive Officer of Clinical Innovations, LLC, a developer and manufacturer of medical devices and diagnostics for women’s health. From 2000 to 2013, she served in a number of key roles at Hologic, Inc. and Cytyc Corporation, which merged with Hologic in October 2007, including Vice President and General Manager of Hologic’s GYN Surgical Products division, as well as various sales and marketing leadership roles in the U.S. and Europe. Ms. Petrovic earned her Bachelor of Science in Biology from the University of Wisconsin.

What is Shacey Petrovic's net worth?

The estimated net worth of Shacey Petrovic is at least $4.22 million as of October 3rd, 2022. Ms. Petrovic owns 13,695 shares of Insulet stock worth more than $4,218,882 as of December 2nd. This net worth approximation does not reflect any other assets that Ms. Petrovic may own. Additionally, Ms. Petrovic receives a salary of $1,720,000.00 as CEO at Insulet. Learn More about Shacey Petrovic's net worth.

How old is Shacey Petrovic?

Ms. Petrovic is currently 48 years old. There are 7 older executives and no younger executives at Insulet. Learn More on Shacey Petrovic's age.

What is Shacey Petrovic's salary?

As the CEO of Insulet Co., Ms. Petrovic earned a total compensation package of $9,723,273.00 in 2021. Ms. Petrovic earned a salary of $744,616.00, stock awards of $6,399,587.00, options awards of $1,599,792.00, non-equity compensation of $970,578.00, and other compensation of $8,700.00. Learn More on Shacey Petrovic's salary.

How do I contact Shacey Petrovic?

The corporate mailing address for Ms. Petrovic and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected] Learn More on Shacey Petrovic's contact information.

Has Shacey Petrovic been buying or selling shares of Insulet?

Within the last three months, Shacey Petrovic has sold $3,477,000.00 in Insulet stock. Most recently, Shacey Petrovic sold 15,000 shares of the business's stock in a transaction on Monday, October 3rd. The shares were sold at an average price of $231.80, for a transaction totalling $3,477,000.00. Following the completion of the sale, the director now directly owns 13,695 shares of the company's stock, valued at $3,174,501. Learn More on Shacey Petrovic's trading history.

Who are Insulet's active insiders?

Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Wayde McMillan (CFO), and Shacey Petrovic (CEO). Learn More on Insulet's active insiders.

Are insiders buying or selling shares of Insulet?

In the last twelve months, insiders at the medical instruments supplier sold shares 8 times. They sold a total of 69,213 shares worth more than $17,657,573.42. The most recent insider tranaction occured on November, 18th when SVP Dan Manea sold 200 shares worth more than $58,924.00. Insiders at Insulet own 0.9 % of the company. Learn More about insider trades at Insulet.

Information on this page was last updated on 11/18/2022.

Shacey Petrovic Insider Trading History at Insulet

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/3/2022Sell15,000$231.80$3,477,000.0013,695View SEC Filing Icon  
7/1/2022Sell15,000$222.90$3,343,500.0013,695View SEC Filing Icon  
4/4/2022Sell15,000$273.25$4,098,750.0013,607View SEC Filing Icon  
10/1/2021Sell15,000$282.87$4,243,050.00View SEC Filing Icon  
4/1/2021Sell15,000$266.17$3,992,550.0056,589View SEC Filing Icon  
10/5/2020Sell15,000$233.91$3,508,650.0033,813View SEC Filing Icon  
1/2/2020Sell12,500$169.63$2,120,375.0095,530View SEC Filing Icon  
11/1/2019Sell689$145.69$100,380.4194,510View SEC Filing Icon  
9/3/2019Sell649$152.40$98,907.60View SEC Filing Icon  
6/5/2019Sell895$113.00$101,135.0095,559View SEC Filing Icon  
3/6/2019Sell1,066$92.64$98,754.24View SEC Filing Icon  
11/1/2018Sell1,134$86.91$98,555.94View SEC Filing Icon  
9/4/2018Sell960$104.26$100,089.60View SEC Filing Icon  
6/1/2018Sell1,067$94.72$101,066.24View SEC Filing Icon  
3/6/2018Sell1,319$76.81$101,312.39View SEC Filing Icon  
See Full Table

Shacey Petrovic Buying and Selling Activity at Insulet

This chart shows Shacey Petrovic's buying and selling at Insulet by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Insulet Company Overview

Insulet logo
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Read More

Today's Range

Now: $308.06
Low: $300.04
High: $309.00

50 Day Range

MA: $262.68
Low: $212.22
High: $313.00

2 Week Range

Now: $308.06
Low: $181.00
High: $320.00

Volume

199,097 shs

Average Volume

527,224 shs

Market Capitalization

$21.39 billion

P/E Ratio

1,283.58

Dividend Yield

N/A

Beta

0.79